Publications (10) María de los Remedios Gómez Sanz publications

2023

  1. Hematological Alterations after Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy

    Journal of Clinical Medicine, Vol. 12, Núm. 13

2022

  1. Higher prevalence of LAP+ (Latency TGFβ-Associated Peptide) T cells at the tissue level in patients with early gastric cancer

    Cellular Immunology, Vol. 382

  2. Hyperthermic Intraperitoneal Chemotherapy and Recirculation with CO2: A Safe Technique

    Journal of Clinical Medicine, Vol. 11, Núm. 20

  3. Prognostic Factors of Survival in Patients with Peritoneal Metastasis from Colorectal Cancer

    Journal of Clinical Medicine, Vol. 11, Núm. 16

2021

  1. A reliable and standardizable differential PCR and qPCR methodology assesses HER2 gene amplification in gastric cancer

    Biology, Vol. 10, Núm. 6

  2. HLA-G 3’UTR Polymorphisms Are Linked to Susceptibility and Survival in Spanish Gastric Adenocarcinoma Patients

    Frontiers in Immunology, Vol. 12

  3. Prognostic Value of KRAS Gene Mutation on Survival of Patients with Peritoneal Metastases of Colorectal Adenocarcinoma

    International Journal of Surgical Oncology, Vol. 2021

  4. TGFB1 polymorphisms and TGF-β1 plasma levels identify gastric adenocarcinoma patients with lower survival rate and disseminated disease

    Journal of Cellular and Molecular Medicine, Vol. 25, Núm. 2, pp. 774-783

2020

  1. Defects at the posttranscriptional level account for the low TCRζ chain expression detected in gastric cancer independently of caspase-3 activity

    Journal of Immunology Research, Vol. 2020

2019

  1. Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for Gastric Cancer with Peritoneal Carcinomatosis: Multicenter Study of Spanish Group of Peritoneal Oncologic Surgery (GECOP)

    Annals of Surgical Oncology, Vol. 26, Núm. 8, pp. 2615-2621